Pancolitis a novel early complication of Alemtuzumab for MS treatment
- 1 May 2016
- journal article
- case report
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 7, 83-84
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialThe Lancet, 2012
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trialThe Lancet, 2012
- Faecal carriage of extended-spectrum -lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiologyJournal of Antimicrobial Chemotherapy, 2008